397 related articles for article (PubMed ID: 7849595)
1. Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases.
Saxena A; Qian N; Kovach IM; Kozikowski AP; Pang YP; Vellom DC; Radić Z; Quinn D; Taylor P; Doctor BP
Protein Sci; 1994 Oct; 3(10):1770-8. PubMed ID: 7849595
[TBL] [Abstract][Full Text] [Related]
2. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inhibition of cholinesterases by huperzine A.
Ashani Y; Peggins JO; Doctor BP
Biochem Biophys Res Commun; 1992 Apr; 184(2):719-26. PubMed ID: 1575745
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
[TBL] [Abstract][Full Text] [Related]
5. Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
Ashani Y; Grunwald J; Kronman C; Velan B; Shafferman A
Mol Pharmacol; 1994 Mar; 45(3):555-60. PubMed ID: 8145739
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
9. Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.
Gemma S; Gabellieri E; Huleatt P; Fattorusso C; Borriello M; Catalanotti B; Butini S; De Angelis M; Novellino E; Nacci V; Belinskaya T; Saxena A; Campiani G
J Med Chem; 2006 Jun; 49(11):3421-5. PubMed ID: 16722663
[TBL] [Abstract][Full Text] [Related]
10. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
11. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of cholinesterase inhibition by inorganic mercury.
Frasco MF; Colletier JP; Weik M; Carvalho F; Guilhermino L; Stojan J; Fournier D
FEBS J; 2007 Apr; 274(7):1849-61. PubMed ID: 17355286
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics of mouse acetylcholinesterase complexed with huperzine A.
Tara S; Helms V; Straatsma TP; McCammon JA
Biopolymers; 1999 Oct; 50(4):347-59. PubMed ID: 10423544
[TBL] [Abstract][Full Text] [Related]
15. Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase.
Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Dec; 42(25):5110-9. PubMed ID: 10602696
[TBL] [Abstract][Full Text] [Related]
16. X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (-)-huperzine B: structural evidence for an active site rearrangement.
Dvir H; Jiang HL; Wong DM; Harel M; Chetrit M; He XC; Jin GY; Yu GL; Tang XC; Silman I; Bai DL; Sussman JL
Biochemistry; 2002 Sep; 41(35):10810-8. PubMed ID: 12196020
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivity of cholinesterases from various sources to organophosphate inhibitors with S-alkyl radicals of various lengths].
Kormilitsyn BN; Moralev SN; Khovanskikh AE; Dalimov DN
Zh Evol Biokhim Fiziol; 2003; 39(5):405-9. PubMed ID: 14689726
[No Abstract] [Full Text] [Related]
18. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Chem Biol Interact; 1999 May; 119-120():61-9. PubMed ID: 10421439
[TBL] [Abstract][Full Text] [Related]
19. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors.
Radić Z; Pickering NA; Vellom DC; Camp S; Taylor P
Biochemistry; 1993 Nov; 32(45):12074-84. PubMed ID: 8218285
[TBL] [Abstract][Full Text] [Related]
20. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
